⚠ Evidence note: An aging clock is a statistical model, not a measurement of aging itself; predictive validity varies widely between clocks and populations.
cis P-tau as Early Biomarker
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-12 — The Pin1-cis P-tau Axis: A Key Common Early Pathogenic Driver, Biomarker and Therapeutic Target Across Neurodegenerative, Traumatic, and Vascular Cognitive Disorders.: 2026 review synthesis proposes the Pin1–cis P-tau axis as a convergent early driver, biomarker, and cis-specific immunotherapy target spanning AD, TBI/CTE, and vascular cognitive disorders; no new primary human readout. [expert-opinion] (novelty: 3)
Open questions
Related
Contributing findings
The Pin1-cis P-tau Axis: A Key Common Early Pathogenic Driver, Biomarker and Therapeutic Target Across Neurodegenerative, Traumatic, and Vascular Cognitive Disorders.
12-sep-2026
novelty 3
per-area 3
strengthens